Disseminated intravascular coagulationLEVI, M; TEN CATE, H.The New England journal of medicine. 1999, Vol 341, Num 8, pp 586-592, issn 0028-4793Article

QUANTITATIVE CHROMOGENIC ENDOTOXIN DETERMINATION IN CEREBROSPINAL FLUIDTHOMAS LLM; TEN CATE H; STURK A et al.1983; CLINICA CHIMICA ACTA; ISSN 0009-8981; NLD; DA. 1983; VOL. 127; NO 1; PP. 137-139; BIBL. 9 REF.Article

The association of disseminated intravascular coagulation with specific diseasesKRAMER, J; OTTEN, H. M; LEVI, M et al.Réanimation (Paris. 2001). 2002, Vol 11, Num 8, pp 575-583, issn 1624-0693, 9 p.Article

Low molecular weight heparin(oid)s : Clinical investigations and practical recommendationsNURMOHAMED, M. T; TEN CATE, H; TEN CATE, J. W et al.Drugs (Basel). 1997, Vol 53, Num 5, pp 736-751, issn 0012-6667Article

Thrombin-mediated activation of endogenous factor XI in plasma in the presence of physiological glycosaminoglycans occurs only with high concentrations of thrombinWUILLEMIN, W. A; MERTENS, K; TEN CATE, H et al.British journal of haematology. 1996, Vol 92, Num 2, pp 466-472, issn 0007-1048Article

Pathogenesis of disseminated intravascular coagulation in sepsisLEVI, M; TEN CATE, H; VAN DER POLL, T et al.JAMA, the journal of the American Medical Association. 1993, Vol 270, Num 8, pp 975-979, issn 0098-7484Article

Disseminated intravascular coagulation : Clinical spectrum and established as well as new diagnostic approachesMÜLLER-BERGHAUS, G; TEN CATE, H; LEVI, M et al.Thrombosis and haemostasis. 1999, Vol 82, Num 2, pp 706-712, issn 0340-6245Article

Clinical manifestations and diagnosis of DICTEN CATE, H.Sepsis (Boston). 1999, Vol 3, Num 2, pp 147-151, issn 1385-0229Article

Clinical applications of new antithrombotic agentsBEIJERING, R. J. R; TEN CATE, H; TEN CATE, J. W et al.Annals of hematology (Print). 1996, Vol 72, Num 4, pp 177-183, issn 0939-5555Article

The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemiaLEVI, M; VAN DER POLL, T; TEN CATE, H et al.European journal of clinical investigation. 1997, Vol 27, Num 1, pp 3-9, issn 0014-2972Article

Disseminated intravascular coagulationLEVI, M; DE JONGE, E; VAN DER POLL, T et al.Thrombosis and haemostasis. 1999, Vol 82, Num 2, pp 695-705, issn 0340-6245Article

What role do coagulation disorders play in the pathogenesis of leptospirosis?WAGENAAR, J. F. P; GORIS, M. G. A; SAKUNDARNO, M. S et al.TM & IH. Tropical medicine & international health. 2007, Vol 12, Num 1, pp 111-122, issn 1360-2276, 12 p.Article

Complete inhibition of endotoxin-induced coagulation activation in chimpanzees with a monoclonal fab fragment against factor VII/VIIaBIEMOND, B. J; LEVI, M; TEN CATE, H et al.Thrombosis and haemostasis. 1995, Vol 73, Num 2, pp 223-230, issn 0340-6245Article

Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzeesLEVI, M; TEN CATE, H; BAUER, K. A et al.The Journal of clinical investigation. 1994, Vol 93, Num 1, pp 114-120, issn 0021-9738Article

Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzeesKUIPERS, B; VAN DER POLL, T; LEVI, M et al.The Journal of immunology (1950). 1994, Vol 152, Num 5, pp 2438-2446, issn 0022-1767Article

Release of soluble receptors for tumor necrosis factor in clinical sepsis and experimental endotoxemiaVAN DER POLL, T; JANSEN, J; VAN LEENEN, D et al.The Journal of infectious diseases. 1993, Vol 168, Num 4, pp 955-960, issn 0022-1899Article

Factor IXa-factor VIIIa-cell surface complex does not contribute to the basal activation of the coagulation mechanism in vivoBAUER, K. A; MANNUCCI, P. M; GRINGERI, A et al.Blood. 1992, Vol 79, Num 8, pp 2039-2047, issn 0006-4971Article

Prevention of deep vein thrombosis following total hip replacement by low molecular weight heparinoidHOEK, J. A; NURMOHAMED, M. T; HAMELYNCK, K. J et al.Thrombosis and haemostasis. 1992, Vol 67, Num 1, pp 28-32, issn 0340-6245Article

Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humansBAUER, K. A; TEN CATE, H; BARZEGAR, S et al.Blood. 1989, Vol 74, Num 1, pp 165-172, issn 0006-4971Article

Use of a heparinoid in patients with hemorrhagic stroke and thromboembolic diseaseTEN CATE, H; HENNY, C. P; BÜLLER, H. R et al.Annals of neurology. 1984, Vol 15, Num 3, pp 268-270, issn 0364-5134Article

Activation of clotting factors XI and IX in patients with acute myocardial infarctionMINNEMA, M. C; PETERS, R. J. G; DE WINTER, R et al.Arteriosclerosis, thrombosis, and vascular biology. 2000, Vol 20, Num 11, pp 2489-2493, issn 1079-5642Article

The 20210 G→ A mutation in the 3'-untranslated region of the prothrombin gene and the risk for arterial thrombotic diseaseFRANCO, R. F; TRIP, M. D; TEN CATE, H et al.British journal of haematology. 1999, Vol 104, Num 1, pp 50-54, issn 0007-1048Article

Differential effects of anti-cytokine treatment on bronchoalveolar hemostasis in endotoxemic chimpanzeesLEVI, M; VAN DER POLL, T; TEN CATE, H et al.American journal of respiratory and critical care medicine. 1998, Vol 158, Num 1, pp 92-98, issn 1073-449XArticle

Activation of the intrinsic pathway of coagulation in children with meningococcal septic shockWUILLEMIN, W. A; FIJNVANDRAAT, K; DERKX, B. H. F et al.Thrombosis and haemostasis. 1995, Vol 74, Num 6, pp 1436-1441, issn 0340-6245Article

Pentoxifylline attenuates neutrophil activation in experimental endotoxemia in chimpanzeesVAN LEENEN, D; VAN DER POLL, T; LEVI, M et al.The Journal of immunology (1950). 1993, Vol 151, Num 4, pp 2318-2325, issn 0022-1767Article